Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: An amphibious vehicle power train having an engine (2) with an output shaft (4), driving an input member (6) of a variable speed change transmission (11). The speed change transmission, which may be a continuously variable transmission is arranged to drive road wheels through an output member (8). The engine also drives a marine propulsion unit (24). The axis of the output member (8) is above the axis of the input member (6). Four wheel drive may be provided (FIG. 2).

Abstract: There are provided according to the invention compounds of formula (I) in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: The present disclosure presents methods and apparatuses for improved tune away in dual-SIM, dual-standby user equipment (UE) in a wireless environment. For example, in an aspect, the present disclosure presents a method of improving active calls in a wireless environment, which may include establishing an active call on a first subscription associated with a first subscriber identification module (SIM) in a multi-standby user UE. In an additional aspect, such example methods may include limiting one or more idle mode procedures of a second subscription associated with a second SIM in the multi-standby UE to non-critical idle mode procedures. Furthermore, in some examples, the one or more idle mode procedures may include cell reselection procedures.

Abstract: Enhanced message notification is provided by an enhanced notification function element and a subscriber preference profile database. The enhanced notification function element queries the subscriber preference profile database to obtain subscriber communication terminal capabilities information, which it uses to select a message notification technology. The enhanced notification function element may then format an enhanced notification that is delivered to a communication terminal through a delivery system architecture appropriate for the selected message notification technology. The enhanced notification may contain: a message type indicator; an identifier of the party leaving the message; a date and time that the message was deposited; multimedia objects; and other enhanced information. The enhanced notification function element may also query a terminal roaming status database in order to determine if the enhanced message should be sent when the terminal is roaming.

Abstract: Pre-authorized communication services and/or transactions are provided via a plurality of networks in response to a request received from a user to provide at least one of a communication service, a transaction and user account information via a plurality of networks of different types. Prior to processing the request, there is verification of the user's authorization to receive the at least one of the communication service, the transaction, and the user account information, and that an account associated with the user has a sufficient amount currently available for payment of the at least one of the communication service and the transaction. After verification, an authorized account associated with the user is charged in real time as the at least one of the communication service and the transaction is provided.

Abstract: A method of determining the weight distribution of a population is provided, including the steps of a) determining a likely weight range for members within the population; b) enabling a plurality of members of the population to impact on a weighing device wherein multiple members may be on the weighing device at one time; c) recording inputs from the weighing device wherein each input corresponds to the presence of the multiple members on the weighing device at one time; and d) using values derived from the inputs and applying an algorithm to specify a number of subsets, each of the subsets representing a discrete number or proportion of members with weight values associated with same.

Abstract: Methods of treating, preventing or managing triple negative breast cancer (TNBC) or clear cell renal cell carcinoma (ccRCC) are disclosed. The methods encompass the administration of an HDAC inhibitor romidepsin in combination with a cytidine analog. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.

Abstract: Cement compositions comprising polymeric particles with inorganic fillers have utilities in the context of well cementing. The fillers improve bonding between the polymeric particles and the cement matrix leading to improved mechanical parameters of the cement system. The filled particles may also lead to improved mixability and slurries that are easier to optimise.

Abstract: The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I).

Abstract: The present invention relates to an inhalation-activatable device for administration of medicament in powder form to the respiratory system of a patient.

Abstract: A primer-less coating composition for facestock comprises: a binder being a water-dispersible polymer; an ethylenically unsaturated compound which is aqueous-dispersible and miscible with or bonded to said water-dispersible polymer, wherein said ethylenically unsaturated compound is able to form a covalent bond with an ink; and a crosslinker, wherein said crosslinker is suitable for binding the coating to the facestock. The coating composition may be applied to a substrate to form a printable film. A printed film in accordance with the invention may be used in a label, for example for use on a container such as a bottle.

Abstract: A microlectrode comprising a diamond layer formed from electrically non-conducting diamond and containing one or more pins or projections of electrically conducting diamond extending at least partially through the layer of non-conducting diamond presenting areas of electrically conducting diamond.

Abstract: A magnet assembly has a number of axially-aligned coils, the radial mid-point of each coil being axially-aligned with a portion of a radial extent of an adjacent coil in the assembly. Compression blocks are provided between adjacent coils at circumferential intervals, to retain the coils in fixed relative positions.

Abstract: A method of consolidating a fracture in a formation comprises injecting a solution of an alkali metal silicate into the formation causing the solution to react with the surfaces of the calcium containing inorganic compound deposits, locking the fine material on these surfaces in place and preventing fines generation during production in a well.

Abstract: The invention relates to a combination which comprises: (a) a HDAC inhibitor; and (b) an anti-thrombocytopenia drug, for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of a proliferative diseases.